Irinotecan plus folinic acid/continuous 5-fluorouracil as simplified bimonthly FOLFIRI regimen for first-line therapy of metastatic colorectal cancer

被引：0
|
作者：
Andreas Teufel
Silke Steinmann
Jürgen Siebler
Christiane Zanke
Herbert Hohl
Bernd Adami
M Schroeder
O Klein
Thomas Höhler
Peter R Galle
Michael Heike
Markus Moehler
机构：
[1] Johannes Gutenberg University,Dept. of Internal Medicine I, Outpatient Unit for GI Cancer
[2] Hospital Bad Ems,undefined
[3] Outpatient Unit,undefined
[4] General practice,undefined
[5] General practice,undefined
[6] General practice,undefined
来源：
BMC Cancer | / 4卷
关键词：
irinotecan; 5-fluorouracil; safety; metastatic colorectal cancer; neoadjuvant;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Irinotecan plus folinic acid/continuous 5-fluorouracil as simplified bimonthly FOLFIRI regimen for first-line therapy of metastatic colorectal cancer -: art. no. 38
    Teufel, A
    Steinmann, S
    Siebler, J
    Zanke, C
    Hohl, H
    Adami, B
    Schroeder, M
    Klein, O
    Höhler, T
    Galle, PR
    Heike, M
    Moehler, M
    BMC CANCER, 2004, 4 (1)
  • [2] Use of the folinic acid/5-fluorouracil/irinotecan (FOLFIRI 1) regimen in elderly patients as a first-line treatment for metastatic colorectal cancer: a Phase II study
    Eric François
    Jean-François Berdah
    Emmanuel Chamorey
    Gérard Lesbats
    Eric Teissier
    Jean-François Codoul
    Jean-Luc Badetti
    Christophe Hébert
    Véronique Mari
    Cancer Chemotherapy and Pharmacology, 2008, 62 : 931 - 936
  • [3] Use of the folinic acid/5-fluorouracil/irinotecan (FOLFIRI 1) regimen in elderly patients as a first-line treatment for metastatic colorectal cancer:: a Phase II study
    Francois, Eric
    Berdah, Jean-Francois
    Chamorey, Emmanuel
    Lesbats, Gerard
    Teissier, Eric
    Codoul, Jean-Francois
    Badetti, Jean-Luc
    Hebert, Christophe
    Mari, Veronique
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 62 (06) : 931 - 936
  • [4] An oxaliplatin plus 5-fluorouracil bolus plus folinic acid (BFOL) regimen as first-line treatment in metastatic colorectal cancer patients
    La Verde, Nicla
    Garassino, Marina
    Bareggi, Claudia
    Sburlati, Paola
    Borgonovo, Karen
    Dimaiuta, Mariastella
    Mantica, Cristina
    Perrone, Silvia
    Torri, Valter
    Farina, Gabriella
    TUMORI, 2007, 93 (06) : 557 - 561
  • [5] Cetuximab in combination with irinotecan/5-fluorouracil (5-FU)/folinic acid (FA) (FOLFIRI) in the first-line treatment of metastatic colorectal cancer (mCRC)
    Peeters, M.
    Raoul, J.-L.
    Van Laethem, J.-L.
    Rougier, P.
    Brezault, C.
    Husseini, F.
    Cals, L.
    Zubel, A.
    Vedovato, J.-C.
    EJC SUPPLEMENTS, 2005, 3 (02): : 188 - 188
  • [6] An alternating regimen of irinotecan/5-fluorouracil/folinic acid and oxaliplatin/5-fluorouracil/folinic acid in metastatic colorectal cancer: A phase II trial
    Ferrari, V
    Valcamonico, F
    Amoroso, V
    Simoncini, E
    Vassalli, L
    Marpicati, P
    Rangoni, G
    Grisanti, S
    Pasinetti, N
    Marini, G
    ONCOLOGY, 2005, 69 (04) : 283 - 289
  • [7] Irinotecan combined or alternated with bolus 5-fluorouracil and folinic acid versus the Mayo Clinic regimen in the first-line therapy of advanced colorectal cancer
    Graeven, U
    Ridwelski, K
    Artandi, M
    Espana, P
    Schölmerich, J
    Rosales, AM
    Carlsson, G
    Borner, M
    Boussard, B
    Schmiegel, W
    ONCOLOGY REPORTS, 2005, 13 (04) : 681 - 688
  • [8] Irinotecan combined with bolus 5-fluorouracil and folinic acid Nordic schedule as first-line therapy in advanced colorectal cancer
    Glimelius, B
    Ristamäki, R
    Kjaer, M
    Pfeiffer, P
    Skovsgaard, T
    Tveit, KM
    Linné, T
    Frödin, JE
    Boussard, B
    Oulid-Aïssa, D
    Pyrhönen, S
    ANNALS OF ONCOLOGY, 2002, 13 (12) : 1868 - 1873
  • [9] Phase II study of infusional 5-fluorouracil, leucovorin, and irinotecan (FOLFIRI) plus bevacizumab as first-line treatment for metastatic colorectal cancer
    Kopetz, S.
    Glover, K. Y.
    Eng, C.
    Wolff, R. A.
    Chang, D. Z.
    Adinin, R. B.
    Morris, J.
    Abbruzzese, J. L.
    Hoff, P. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [10] First-line panitumumab plus irinotecan/5-fluorouracil/leucovorin treatment in patients with metastatic colorectal cancer
    Claus-Henning Köhne
    Ralf Hofheinz
    Laurent Mineur
    Henry Letocha
    Richard Greil
    Josef Thaler
    Eva Fernebro
    Erick Gamelin
    Lucy DeCosta
    Meinolf Karthaus
    Journal of Cancer Research and Clinical Oncology, 2012, 138 : 65 - 72
12345